Ensign Group
$177.35
▼ -0.45%
−$0.81
NYSE · Healthcare · Medical Care Facilities
· price updated 9h ago
ENSG · NYSE · Healthcare · Medical Care Facilities · price updated 9h ago
$177.35
▼ -0.45% · −$0.81 today
AI research · $177.35
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Middle ground · 10% above Sector avg
21.70x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
1.88x
Price / FCF
Price against free cash generation
Reasonable · Between 20x and 35x free cash flow
24.57x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
26.69x
Quality
ROIC
Return earned on invested capital
Reasonable · An 8% to 15% return on capital
8.5%
ROE
Profit generated from shareholder equity
Favorable · Ahead of most sector peers
17.0%
Debt / equity
Balance-sheet leverage
Middle ground · Roughly in line with sector
0.92x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.21x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $10.38B | 27.9 | +18.9% | 65 | |
| $10.69B | 18.4 | +23.5% | 78 | |
| $4.88B | 20.3 | +10.3% | 77 | |
| $31.49B | 32.9 | +15.5% | 77 | |
| $1.08T | 41.4 | +47.4% | 76 |
US stock research
Ensign Group tracked in the US core universe. ENSG was -0.5% in the latest available session at $177.35. Its reported market value was $10.38B with a trailing P/E of 27.9. Latest reported revenue was $5.49B, changing +18.9% year over year, with $283.25M in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.